摘要:
The present invention discloses the production of recombinant proteins of the virus causing the porcine respiratory and reproductive syndrome (PRRS), corresponding to the ORFs 2-7 of the PRRSV isolated in Spain, (PRRS-Olot), in a system of expression of recombinant baculoviruses multiplided in a cell culture of a permissive host. Said recombinant proteins are appropriate to formulate vaccines capable of efficiently protecting pigs against PRRS as well as to prepare diagnotic kits appropriate to detect both the presence of antibodies which recognize PRRSV and the presence of PRRSV in a porcine biological sample. This invention applies to veterinary.
摘要:
The present invention relates to the coat protein genes of Papaya Ringspot Virus Strain papaya ringspot (PRV-p), Watermelon Mosaic Virus II (WMVII), and Zucchini Yellow Mosaic Virus (ZYMV); to expression vectors which contain a coat protein gene for PVP-p, WMVII or ZYMV, and, additionally, the necessary genetic regulatory sequences needed for expression of a gene transferred into a plant; to bacterial or plant cells which are transformed with an expression vector containing the PVP-p, WMVII or ZYMV coat protein genes; to transgenic plants which are produced from plant cells transformed with an expression vector containing the coat protein gene from PVP-p, WMVII or ZYMV; and to a process of producing transgenic plants which have increased resistance to viral infection.
摘要:
Provided is an mRNA vaccine, said mRNA vaccine containing an immune cell targeting molecule that is expressed in fusion with an antigen and enhances the immunological effectiveness of an mRNA vaccine.
摘要:
The present invention is a method for detecting hepatitis E virus infection, comprising a detection step of detecting anti-hepatitis E virus antibodies in a sample by using, as an antigen polypeptide, at least one polypeptide selected from the group consisting of the following (a) to (c): (a) a polypeptide consisting of an amino acid sequence which includes amino acids located at position 28 to 175 in the amino acid sequence set forth in any one of SEQ ID NOs: 1 to 4 and which has a full length of 200 residues or less that are contained in the amino acid sequence set forth in the sequence number; (b) a polypeptide consisting of an amino acid sequence in which one or more amino acids are substituted, deleted, inserted, and/or added in the amino acid sequence which includes amino acids located at position 28 to 175 in the amino acid sequence set forth in any one of SEQ ID NOs: 1 to 4 and which has a full length of 200 residues or less that are contained in the amino acid sequence set forth in the sequence number; and (c) a polypeptide consisting of an amino acid sequence having 80% or more homology with the amino acid sequence which contains amino acids located at position 28 to 175 in the amino acid sequence set forth in any one of SEQ ID NOs: 1 to 4 and which has a full length of 200 residues or less that are contained in the amino acid sequence set forth in the sequence number.